10 employees
Avexegen Therapeutics is a biotechnology company developing therapies for gastrointestinal disorders.
2014
$2.9M
from 2 investors over 2 rounds
Avexegen Therapeutics Inc. raised $2.9M on February 15, 2021
Investors: National Institutes of Health
Avexegen Therapeutics Inc. raised undisclosed on January 1, 2018
Investors: Mission BioCapital